3Martinez-Monge R,Nag S,Nieroda CA,et al.Iodine-^125 brachytherapy in the treatment of colorectal adenocarcinoma metastatic to the liver[J].Cancer,1999,85(6):1218-1225. 被引量：1
4Videtic GM,Gaspar LE,Zamorano L,et al.Use of the RTOG recursive partitioning analysis to validate the benefit of iodine-^125 implants in the primary treatment of malignant gliomas[J].Int J Radiat Oncol Bilo Pyhys,1999,45(3):687-692. 被引量：1
5Nag S,Scaperoth DD,Badalament R,et al.Transperineal palladium 103 prostate brachytherapy:anaysis of morbidity and seed migration[J].Urology,1995,45(1):87-92. 被引量：1
6Nag S,Vivekanandam S,Martinez-Monge R.Pulmonary embolization of permanently implanted radioactive palladium-103 seeds for carcinoma of the prostate[J].Int J Radiat Oncol Biol Phys,1997,39(3):667-670. 被引量：1
8Chen QS,Russell JL Jr,Macklis RR,et al.Dosimetry of a thyroid uptake detected in seed migration survey following a patient's iodine-^125 prostate implant and in vitro measurements of intentional seed leakages[J].Med Phys,2006,33(7):2384-2390. 被引量：1
二级参考文献12
1Nori D, Moni FJ. Current issues in techniques of prostate brachytherapy[J]. Semin Surg Oncol, 1997, 13: 444-453. 被引量：1
2Parker SL, Tong T, Bolden S, et al. Cancer statistics, 1997[J]. CA J Clin, 1997, 47: 5-27. 被引量：1
3Vicini FA, Horwitz EM, Gonzalez J, et al. Treatment options for localized prostate cancer based upon pretreatment prostate specific antigen levels[J]. J Urol, 1997, 158: 319-325. 被引量：1
4Vicini FA, Horwitz EM, Kini VR, et al. Radiotherapy options for localized prostate cancer based upon pretreatment serum prostate specific antigen levels and biochemical control: A comprehensive review of the literature[J]. Int J Radiat Oncol Biol Phys, 1998, 40:1101-1110. 被引量：1
5Horwitz EM, Vicini FA, Ziaja EL, et al. Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of bioeheroieal control [J]. Int J Radiat Oncol Biol Phys, 1996, 36: 565-575. 被引量：1
6Hilaris RS. Brachytherapy in cancer of the prostate: an historical perspective[J]. Semin Surg Oncol, 1997, 13: 399-405. 被引量：1
7Vicini FA, Kini VR, Edmundson G, et al. A comprehensive review of prostate cancer brachytherapy: difining an optimal technique[J]. Int J Radiat Oncol Biol Phys, 1999, 44: 483-491. 被引量：1
8Blasko JC, Wallner K, Grimm PD, et al. Prostate specific antigen based disease control following ultrasound guided 125-iodine implantation for stage T1/T2 prostatic carcinoma[J]. J Urol, 1995, 154: 1096-1099. 被引量：1
9Mate TP, Gottesman JE, Hatton J, et al. High dose-rate afterloading 192-iridium prostate brachytherapy: Feasibility report [J]. Int J Radiat Oncol Biol Phys, 1998, 41: 525-533. 被引量：1
10Wallner K, Roy J, Harrison L. Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma[J]. J Clin Oncol, 1996, 14: 449-453. 被引量：1
